サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788311

希少細胞分離の世界市場

Rare Cell Isolation

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
希少細胞分離の世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

希少細胞分離の世界市場は2030年までに37億米ドルに達する

2024年に21億米ドルと推定される希少細胞分離の世界市場は、2024年から2030年にかけてCAGR 9.8%で成長し、2030年には37億米ドルに達すると予測されます。希少細胞分離試薬・キットは、本レポートで分析しているセグメントの1つであり、CAGRは10.9％を記録し、分析期間終了時には28億米ドルに達すると予測されています。希少細胞分離Instrumentsセグメントの成長率は、分析期間中CAGR 6.9％と推定されます。

米国市場は5億6,200万米ドル、中国はCAGR 9.4％で成長予測

米国の希少細胞分離市場は、2024年に5億6,200万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5億9,300万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.1%と8.2%と予測されています。欧州では、ドイツがCAGR約7.7%で成長すると予測されています。

世界の希少細胞分離市場- 主要動向と促進要因のまとめ

希少細胞分離が生物医学調査において重要なツールになりつつある理由とは？

希少細胞分離は、がん診断、出生前スクリーニング、感染症モニタリングにおいて重要な役割を果たす低存在細胞の同定と解析を可能にし、バイオメディカル研究において重要な技術として台頭してきました。従来の細胞分析法では、血液や組織サンプル中に極低濃度で存在する希少な循環腫瘍細胞（CTC）、胎児細胞、幹細胞を検出できないことが多いです。マイクロ流体工学、蛍光活性化セルソーティング（FACS）、磁気活性化セルソーティング（MACS）などの高度な希少細胞分離技術は、これらの細胞を高精度で捕捉し研究する能力に革命をもたらしました。疾患の早期発見と個別化医療へのニーズの高まりは、特に腫瘍学とリキッドバイオプシー・アプリケーションにおいて、希少細胞分離テクノロジーへの需要を加速させています。免疫療法、再生医療、マイクロバイオーム解析の研究が進むにつれて、希少細胞分離は標的治療戦略の開発において重要な役割を果たし続けるでしょう。

技術革新はどのように希少細胞分離を強化しているのか？

ナノテクノロジー、シングルセルシーケンス、ラボオンチップ技術におけるブレークスルーは、希少細胞分離法の効率と精度を著しく向上させました。マイクロ流体プラットフォームの開発により、血液サンプルの自動化されたハイスループット処理が可能になり、手作業を減らし、細胞の損失を最小限に抑えることができるようになりました。次世代シーケンサー（NGS）と単離された希少細胞との統合により、研究者は疾患の進行に関連する遺伝子変異を明らかにすることができ、より正確な診断・治療アプローチにつながっています。AIを駆使した画像認識システムも希少細胞分離のワークフローに組み込まれ、標的細胞を非特異的な残骸と区別し、感度と特異性を高めています。さらに、免疫磁性ビーズを用いた分離技術の進歩により、希少細胞集団の迅速かつスケーラブルな分離が容易になっています。このような技術革新により、希少細胞分離はより利用しやすく、費用対効果に優れ、信頼できるものとなり、臨床および研究用途での採用が進んでいます。

どのような市場動向が希少細胞分離技術の採用を促進していますか？

がんの早期発見とリキッドバイオプシーに基づく診断への重点の高まりは、希少細胞分離技術採用の主要な促進要因の一つです。リキッドバイオプシーが、非侵襲的ながんスクリーニングや治療モニタリングで支持されるようになるにつれ、効率的な希少細胞分離技術は、循環腫瘍細胞（CTC）や無細胞DNA（cfDNA）を捕捉するために不可欠です。個別化医療や標的治療の拡大により、シングルセル解析の需要はさらに高まっており、希少細胞分離は患者固有のバイオマーカーを特定する上で重要な役割を果たしています。CAR-T細胞療法を含む細胞ベースの免疫療法の台頭も、希少な免疫細胞集団の単離と工学的解析の研究を加速させています。さらに、出生前診断や母体血液からの胎児細胞分離に注目が集まっていることで、非侵襲的遺伝子スクリーニングの新たな機会が生まれています。精密医療がヘルスケアの形を変え続ける中、希少細胞分離は次世代診断と治療の重要な実現者であり続けると予想されます。

希少細胞分離市場の主な成長促進要因は？

世界の希少細胞分離市場の成長は、マイクロ流体技術やシングルセル解析技術の進歩、リキッドバイオプシー診断の採用拡大、免疫療法や再生医療の研究拡大など、いくつかの要因によって牽引されています。がんや感染症の有病率の上昇により、早期発見ツールの必要性が高まっており、高感度希少細胞分離法の需要を煽っています。さらに、細胞選別システムにおけるAIと自動化の統合は、効率性と拡張性を向上させ、希少細胞分離の臨床応用をより現実的なものにしています。バイオ医薬品研究の拡大は、精密医療イニシアティブへの投資の増加と相まって、市場の成長をさらに加速させています。ヘルスケアや研究機関が病気の早期発見、個別化治療、非侵襲的診断法を優先し続ける中、希少細胞分離市場は大きく拡大し、医療診断やバイオテクノロジー研究の展望を一変させる勢いです。

セグメント

製品タイプ（希少細胞分離試薬＆キット、希少細胞分離機器）;細胞タイプ（幹細胞、循環腫瘍細胞、胎児細胞、希少免疫細胞、循環内皮細胞、その他の細胞タイプ）;技術（マイクロ流体ベース技術、蛍光活性化セルソーティング技術、磁気ビーズ分離技術）

調査対象企業の例

  • Akadeum Life Sciences, Inc.
  • Applied Cells
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioFluidica
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • CELLENION
  • Danaher Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Rarecells Diagnostics
  • RareCyte, Inc.
  • SEED Biosciences
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32758

Global Rare Cell Isolation Market to Reach US$3.7 Billion by 2030

The global market for Rare Cell Isolation estimated at US$2.1 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Rare Cell Isolation Reagent & Kits, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Rare Cell Isolation Instruments segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$562.0 Million While China is Forecast to Grow at 9.4% CAGR

The Rare Cell Isolation market in the U.S. is estimated at US$562.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$593.0 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Rare Cell Isolation Market - Key Trends & Drivers Summarized

Why Is Rare Cell Isolation Becoming a Crucial Tool in Biomedical Research?

Rare cell isolation has emerged as a critical technique in biomedical research, enabling the identification and analysis of low-abundance cells that play a vital role in cancer diagnostics, prenatal screening, and infectious disease monitoring. Traditional methods of cell analysis often fail to detect rare circulating tumor cells (CTCs), fetal cells, and stem cells present in extremely low concentrations in blood and tissue samples. Advanced rare cell isolation techniques, including microfluidics, fluorescence-activated cell sorting (FACS), and magnetic-activated cell sorting (MACS), have revolutionized the ability to capture and study these cells with high precision. The growing need for early disease detection and personalized medicine has accelerated demand for rare cell isolation technologies, particularly in oncology and liquid biopsy applications. As research in immunotherapy, regenerative medicine, and microbiome analysis advances, rare cell isolation will continue to play a pivotal role in developing targeted treatment strategies.

How Are Technological Innovations Enhancing Rare Cell Isolation?

Breakthroughs in nanotechnology, single-cell sequencing, and lab-on-a-chip technology have significantly improved the efficiency and accuracy of rare cell isolation methods. The development of microfluidic platforms has enabled automated, high-throughput processing of blood samples, reducing manual intervention and minimizing cell loss. Next-generation sequencing (NGS) integration with isolated rare cells is allowing researchers to uncover genetic mutations linked to disease progression, leading to more precise diagnostic and therapeutic approaches. AI-powered image recognition systems are also being incorporated into rare cell isolation workflows to distinguish target cells from non-specific debris, enhancing sensitivity and specificity. Additionally, advancements in immunomagnetic bead-based isolation techniques are facilitating rapid and scalable separation of rare cell populations. These technological innovations are making rare cell isolation more accessible, cost-effective, and reliable, driving its adoption across clinical and research applications.

What Market Trends Are Driving the Adoption of Rare Cell Isolation Technologies?

The increasing emphasis on early cancer detection and liquid biopsy-based diagnostics is one of the primary drivers of rare cell isolation technology adoption. As liquid biopsies gain traction in non-invasive cancer screening and treatment monitoring, efficient rare cell isolation techniques are essential for capturing circulating tumor cells (CTCs) and cell-free DNA (cfDNA). The expansion of personalized medicine and targeted therapies has further increased the demand for single-cell analysis, where rare cell isolation plays a critical role in identifying patient-specific biomarkers. The rise of cell-based immunotherapy, including CAR-T cell therapy, has also accelerated research on isolating and engineering rare immune cell populations. Additionally, the growing focus on prenatal diagnostics and fetal cell isolation from maternal blood is creating new opportunities for non-invasive genetic screening. As precision medicine continues to reshape healthcare, rare cell isolation is expected to remain a key enabler of next-generation diagnostics and treatments.

What Are the Key Growth Drivers of the Rare Cell Isolation Market?

The growth in the global rare cell isolation market is driven by several factors, including advancements in microfluidic and single-cell analysis technologies, increasing adoption of liquid biopsy diagnostics, and expanding research in immunotherapy and regenerative medicine. The rising prevalence of cancer and infectious diseases has heightened the need for early detection tools, fueling demand for high-sensitivity rare cell isolation methods. Additionally, the integration of AI and automation in cell sorting systems is improving efficiency and scalability, making rare cell isolation more viable for clinical applications. The expansion of biopharmaceutical research, coupled with growing investments in precision medicine initiatives, is further accelerating market growth. As healthcare and research institutions continue to prioritize early disease detection, personalized treatments, and non-invasive diagnostic methods, the rare cell isolation market is poised for significant expansion, transforming the landscape of medical diagnostics and biotechnology research.

SCOPE OF STUDY:

The report analyzes the Rare Cell Isolation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Rare Cell Isolation Reagent & Kits, Rare Cell Isolation Instruments); Cell Type (Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells, Other Cell Types); Technology (Microfluidics-based Technology, Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Akadeum Life Sciences, Inc.
  • Applied Cells
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioFluidica
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • CELLENION
  • Danaher Corporation
  • GE Healthcare
  • Illumina, Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Rarecells Diagnostics
  • RareCyte, Inc.
  • SEED Biosciences
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Rare Cell Isolation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Liquid Biopsy Applications Spurs Demand for High-Sensitivity Rare Cell Isolation Technologies
    • Advances in Microfluidics and Nanoparticle-Based Separation Enhance Accuracy and Drive Market Innovation
    • Rising Adoption of Personalized Cancer Diagnostics Throws the Spotlight on Circulating Tumor Cell Isolation
    • Expansion of Immunotherapy and Cell Therapy Research Fuels Need for Precise Cell Enrichment Tools
    • Demand for Non-Invasive Prenatal Testing Propels Use of Fetal Cell Isolation Platforms
    • Development of Automated Isolation Instruments Strengthens High-Throughput Clinical and Research Applications
    • Integration of AI and Image Analysis in Cell Sorting Enhances Workflow and Supports Market Penetration
    • Proliferation of Single-Cell Omics Research Accelerates Adoption of Ultra-Pure Cell Isolation Methods
    • Collaborations Between Diagnostic Labs and Research Institutions Boost Product Development and Customization
    • Stringent Quality Standards in GMP-Compliant Manufacturing Strengthen Business Case for Advanced Isolation Systems
    • Expansion of Liquid Biopsy Companion Diagnostics Generates Sustained Industry Investment
    • Increasing Use of Rare Cells in Biomarker Discovery Spurs Growth in Customizable Isolation Platforms
    • Increased Funding for Cancer Research Worldwide Accelerates Commercialization of Isolation Technologies
    • Emphasis on Minimally Invasive Diagnostics in Neurology and Infectious Disease Broadens Use Cases
    • Rising Demand for Integrated Sample Preparation Systems Drives Innovation in Isolation-Cartridge Design
    • Adoption of Label-Free and Dielectrophoretic Isolation Enhances Specificity and Reduces Contamination Risks
    • Clinical Trials for Cell-Based Therapeutics Spur Demand for Regulatory-Grade Cell Separation Products
    • Use of Rare Cells in Regenerative Medicine Expands Addressable Market Beyond Oncology
    • Technological Miniaturization and Cost Reduction Make High-End Isolation More Accessible
    • Shift Toward Decentralized and Point-of-Care Diagnostics Supports Development of Portable Isolation Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Rare Cell Isolation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Rare Cell Isolation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Rare Cell Isolation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Rare Cell Isolation Reagent & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Rare Cell Isolation Reagent & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Rare Cell Isolation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Rare Cell Isolation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fluorescence-Activated Cell Sorting Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Fluorescence-Activated Cell Sorting Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Bead Separation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Magnetic Bead Separation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Microfluidics-based Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Microfluidics-based Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Circulating Tumor Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Circulating Tumor Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fetal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Fetal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Rare Immune Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Rare Immune Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Circulating Endothelial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Circulating Endothelial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Cell Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Cell Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • JAPAN
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • CHINA
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • EUROPE
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Rare Cell Isolation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • FRANCE
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • GERMANY
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • UNITED KINGDOM
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Rare Cell Isolation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Rare Cell Isolation by Product - Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Rare Cell Isolation by Product - Percentage Breakdown of Value Sales for Rare Cell Isolation Reagent & Kits and Rare Cell Isolation Instruments for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Rare Cell Isolation by Technology - Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Rare Cell Isolation by Technology - Percentage Breakdown of Value Sales for Fluorescence-Activated Cell Sorting Technology, Magnetic Bead Separation Technology and Microfluidics-based Technology for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Rare Cell Isolation by Cell Type - Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Rare Cell Isolation by Cell Type - Percentage Breakdown of Value Sales for Stem Cells, Circulating Tumor Cells, Fetal Cells, Rare Immune Cells, Circulating Endothelial Cells and Other Cell Types for the Years 2025 & 2030

IV. COMPETITION